Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Larson

Showing results (191-200 of 329) with videos related to

Pageof 33
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1996
Pharmacokinetics and dosimetry of iodine-125-IUdR in the treatment of colorectal cancer metastatic to liverF Daghighian, J L Humm, H A Macapinlac, et al.
Cancer Research|August 1, 1987
Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinomaD Colcher, J Esteban, J A Carrasquillo, et al.
Cancer Research|February 15, 1987
Quantitative analyses of selective radiolabeled monoclonal antibody localization in metastatic lesions of colorectal cancer patientsD Colcher, J M Esteban, J A Carrasquillo, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
Detection of hepatic metastases from colorectal carcinoma using indium-111 (111In) labeled monoclonal antibody (mAb): MSKCC experience with mAb 111In-C110C R Divgi, K McDermott, D K Johnson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1994
Transport limits cellular entry of hepatic arterially injected 5-[18F]fluoro-2'-deoxyuridine in human intrahepatic tumorsJ R Bading, E R Sigurdson, R D Finn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1990
Immunoreactivity affects the biodistribution and tumor targeting of radiolabeled anti-P97 Fab fragmentK Yokoyama, J C Reynolds, C H Paik, et al.
European Journal of Nuclear Medicine|September 2, 1998
Radioimmunotherapy with alpha-emitting nuclidesM R McDevitt, G Sgouros, R D Finn, et al.
Cancer Research|October 1, 1988
Measurement of local Mr 97,000 and 250,000 protein antigen concentration in sections of human melanoma tumor using in vitro quantitative autoradiographyS Del Vecchio, J C Reynolds, R G Blasberg, et al.
The Journal of Clinical Endocrinology and Metabolism|July 15, 1999
[18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levelsW Wang, H Macapinlac, S M Larson, et al.
European Journal of Nuclear Medicine|August 22, 2000
Use of PET to monitor the response of lung cancer to radiation treatmentY E Erdi, H Macapinlac, K E Rosenzweig, et al.
Pageof 33

Showing results (191-200 of 329) with videos related to

Sort By:
Pageof 33
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1996
Pharmacokinetics and dosimetry of iodine-125-IUdR in the treatment of colorectal cancer metastatic to liverF Daghighian, J L Humm, H A Macapinlac, et al.
Cancer Research|August 1, 1987
Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72.3) in patients with carcinomaD Colcher, J Esteban, J A Carrasquillo, et al.
Cancer Research|February 15, 1987
Quantitative analyses of selective radiolabeled monoclonal antibody localization in metastatic lesions of colorectal cancer patientsD Colcher, J M Esteban, J A Carrasquillo, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
Detection of hepatic metastases from colorectal carcinoma using indium-111 (111In) labeled monoclonal antibody (mAb): MSKCC experience with mAb 111In-C110C R Divgi, K McDermott, D K Johnson, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 1, 1994
Transport limits cellular entry of hepatic arterially injected 5-[18F]fluoro-2'-deoxyuridine in human intrahepatic tumorsJ R Bading, E R Sigurdson, R D Finn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1990
Immunoreactivity affects the biodistribution and tumor targeting of radiolabeled anti-P97 Fab fragmentK Yokoyama, J C Reynolds, C H Paik, et al.
European Journal of Nuclear Medicine|September 2, 1998
Radioimmunotherapy with alpha-emitting nuclidesM R McDevitt, G Sgouros, R D Finn, et al.
Cancer Research|October 1, 1988
Measurement of local Mr 97,000 and 250,000 protein antigen concentration in sections of human melanoma tumor using in vitro quantitative autoradiographyS Del Vecchio, J C Reynolds, R G Blasberg, et al.
The Journal of Clinical Endocrinology and Metabolism|July 15, 1999
[18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography localizes residual thyroid cancer in patients with negative diagnostic (131)I whole body scans and elevated serum thyroglobulin levelsW Wang, H Macapinlac, S M Larson, et al.
European Journal of Nuclear Medicine|August 22, 2000
Use of PET to monitor the response of lung cancer to radiation treatmentY E Erdi, H Macapinlac, K E Rosenzweig, et al.
Pageof 33